Results 191 to 200 of about 394,248 (332)

TADF Host Engineering for Improved Pure Blue Matrix‐Free Hyperfluorescent OLEDs with Ultranarrow Emission

Advanced Optical Materials, EarlyView.
This work presents the development of efficient blue thermally activated delayed fluorescent (TADF) materials that perform well without doping, enabling simplified, matrix‐free hyperfluorescence (MFHF) OLEDs. When combined with encapsulated narrow‐band emitters, the TADF materials serve as effective hosts resulting in pure blue, ultranarrow emission ...
Hwan‐Hee Cho, Daniel G. Congrave, Sebastian Gorgon, Victor Riesgo‐Gonzalez, Richard H. Friend, Hugo Bronstein   +5 more
wiley   +1 more source

Identification and characterization of new structured RNA classes in plants. [PDF]

RNA Biol
Sack M, Reinhardt M, Burgardt R, Berg P, Bauer J, Wachter A, Weinberg Z.   +6 more
europepmc   +1 more source

Alternative splicing generates variants in important functional domains of human slow skeletal troponin T.

, 1987
Reinhold Gahlmann, Anthony B. Troutt, Robert Wade, Peter W. Gunning, Larry Kedes   +4 more
openalex   +1 more source

Assembly of pre-mRNA splicing complex is cap dependent [PDF]

, 1987
Erik Patzelt, Eva Thalmann, Klaus Hartmuth, D. Blass, Ernst Kuechler   +4 more
openalex   +1 more source

Optical Chaos Generation and Applications

Advanced Photonics Research, EarlyView.
This review comprehensively examines optical chaos generation via feedback, injection, and optoelectronic methods, emphasizing bandwidth enhancement and time‐delay suppression. Applications include chaos‐synchronized secure communication, physical random number generation, chaotic lidar for cm‐level detection, distributed fiber sensing, and terahertz ...
Wenhui Chen, Xiaoxin Mao, Junli Wang, Rong Zhang, Longsheng Wang, Zhiwei Jia, Pu Li, Anbang Wang, Yuncai Wang   +8 more
wiley   +1 more source

<i>BRCA2</i> Pre-mRNA Differential 5' Splicing: A Rescue of Functional Protein Properties from Pathogenic Gene Variants and a Lifeline for Fanconi Anemia D1 Patients. [PDF]

Int J Mol Sci
Paredes R, Batta K, Wiseman DH, Gothbi R, Dalal V, Schmidt CK, Kalb R, Meyer S, Schindler D.   +8 more
europepmc   +1 more source

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

A New High Penetrant Intronic Pathogenic Variant Related to Long QT Syndrome Type 2. [PDF]

J Clin Med
Rodríguez-Junquera M, Alén A, González-Urbistondo F, Rodríguez-Reguero JJ, Fernández B, Álvarez-Velasco R, Vazquez-Coto D, Vega-Prado LM, Avanzas P, Coto E, Gómez J, Lorca R.   +11 more
europepmc   +1 more source

Control of adenovirus E1B mRNA synthesis by a shift in the activities of RNA splice sites.

, 1984
Craig Montell, Eric F. Fisher, Marvin H. Caruthers, Arnold Berk   +3 more
openalex   +1 more source

Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential

Advanced Science, EarlyView.
Current preclinical studies of AAV‐mediated gene therapy explore different strategies based on the characteristics of inner ear diseases. For genetic hearing loss, approaches include the replacement of a “good gene,” removal of a “bad gene,” or direct correction of mutations through base editing.
Fan Wu, Wuhui He, Yun Xiao, Qiong Wu, Qing Zhang, Tiesong Zhang, Lei Xu, Xinyi Pang   +7 more
wiley   +1 more source